The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and tolerability of intraventricular CARv3-TEAM-E T cells following lymphodepleting chemotherapy in recurrent glioblastoma: INCIPIENT trial.
 
Elizabeth Gerstner
Consulting or Advisory Role - Alexion Pharmaceuticals (I); Bayer (I); Biodexa; Bristol Myers (I); Cytokinetics (I); Nuevocure (I); Pfizer (I); Tenaya (I)
 
William Curry
Leadership - IMRIS, Inc
 
Deborah Forst
Stock and Other Ownership Interests - Lilly
 
Alona Muzikansky
No Relationships to Disclose
 
Estelle Emmanuel-Alejandro
No Relationships to Disclose
 
Gabrielle Furman
Employment - Massachusetts General Hospital
Stock and Other Ownership Interests - Agenus; Ensign Group; MiNK Therapeutics; National HealthCare Corporation
 
Daniella Cook
Employment - Massachusetts General Hospital Cancer Center
Research Funding - Massachusetts General Hospital Cancer Center
Travel, Accommodations, Expenses - Adaptimmune
 
Danielle Bernier
No Relationships to Disclose
 
Lu Huang
No Relationships to Disclose
 
Jeremy Ford
No Relationships to Disclose
 
Karen Buch
No Relationships to Disclose
 
Sarah Nikiforow
Consulting or Advisory Role - Atara Biotherapeutics; Iovance Biotherapeutics; Pierre Fabre; Smart Immune; SOBI
Travel, Accommodations, Expenses - A2 Biotherapeutics
 
Kathleen Gallagher
Stock and Other Ownership Interests - ModelT Bio
Travel, Accommodations, Expenses - BD Biosciences
 
Matthew Frigault
Stock and Other Ownership Interests - Immunofree
Consulting or Advisory Role - Bristol-Myers Squibb/Juno; Cytoagents; Gilead Sciences; Novartis
Research Funding - SOBI
Patents, Royalties, Other Intellectual Property - Own IP related to chimeric antigen receptors and T cell manufacturing
 
Marcela Maus
Leadership - 2seventy bio
Stock and Other Ownership Interests - 2seventy bio; A2Bio; Affyimumune; BendBio; CARGO Therapeutics; GBM newco; Model T Bio; NexImmune; Oncternal Therapeutics
Consulting or Advisory Role - Adaptimmune; AffyImmune Therapeutics; Agenus; arcellx; Astellas Pharma; AstraZeneca; Atara Biotherapeutics; Bayer; BMS; Cabaletta Bio; Cabaletta Bio; Chugai Pharma; crispr therapeutics; GlaxoSmithKline; In8bio; In8Bio; Intellia Therapeutics; Kite, a Gilead company; MicroMedicine; Novartis; Oncternal Therapeutics; Sanofi; TCR2 Therapeutics; Tmunity Therapeutics, Inc.; Torque; windmil
Research Funding - Kite, a Gilead company (Inst); Moderna Therapeutics (Inst); Servier (Inst); Sobi (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on patents held by Massachusetts General Hospital/Partners Health care; all related to CAR T cells and/or gene therapy; Inventor on patents held by U. Pennsylvania with and without Novartis
 
Bryan Choi
Consulting or Advisory Role - Third Rock Ventures
Patents, Royalties, Other Intellectual Property - Patents issued regarding the use of CAR T cells and other immune-based therapy for the treatment of cancer.